Andrea Tubaro

Pubblicazioni

Titolo Pubblicato in Anno
Patients with prostatic inflammation undergoing transurethral prostatic resection have a larger early improvement of storage symptoms UROLOGY 2015
Transrectal-ultrasound prostatic biopsy preparation. Rectal enema vs. mechanical bowel preparation CENTRAL EUROPEAN JOURNAL OF UROLOGY 2015
TRENDS IN THE USE OF PARTIAL NEPHRECTOMY FOR CT1 RENAL TUMORS: ANALYSIS OF A 10-YR EUROPEAN MULTICENTER DATASET THE JOURNAL OF UROLOGY 2015
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU INTERNATIONAL 2015
Re: Christian Gratzke, Alexander Bachmann, Aurelien Descazeaud, et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.12.038. EUROPEAN UROLOGY 2015
A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment. BJU INTERNATIONAL 2015
Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study. BJU INTERNATIONAL 2015
Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment. NATURE REVIEWS. UROLOGY 2015
Re: association between metabolic syndrome and severity of lower urinary tract symptoms: an observational study in a 4666 European men cohort. EUROPEAN UROLOGY 2015
Corrigendum to "Quality of Life and Sexual Health in the Aging of PCa Survivors". INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2015
Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride? CURRENT DRUG TARGETS 2015
Clinical research office of the Endourological Society Global GreenLight Laser Study. outcomes from a contemporary series of 713 patients INTERNATIONAL JOURNAL OF UROLOGY 2015
Tolterodine in the treatment of male LUTS CURRENT UROLOGY REPORTS 2015
The management of overactive bladder: Percutaneous tibial nerve stimulation, sacral nerve stimulation, or botulinum toxin? CURRENT OPINION IN UROLOGY 2015
The continuing Story of the Cost-Effectiveness of Photoselective Vaporization of the Prostate versus Transuretheral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Obstruction VALUE IN HEALTH 2015
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4). A double-blind, multicentre, phase 3, randomised, placebo-controlled trial THE LANCET ONCOLOGY 2015
The Current Indications and the Benefits of Combining a β3-Agonist with an Anticholinergic for the Treatment of OAB CURRENT DRUG TARGETS 2015
Reply UROLOGY 2015

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma